Published in Mod Pathol on January 01, 1994
Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group. J Urol (2000) 1.92
Probability in lymph node sectioning. Cancer (1974) 1.75
The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. J Urol (1997) 1.62
Shigella sonnei bacteremia. Unusual antibody response from immunosuppressive therapy following renal transplantation. Urology (1974) 1.53
Tissue section image analysis of breast neoplasms. Evidence of false aneuploidy. Am J Clin Pathol (1993) 1.45
Acute pancreatitis in pregnancy: a review of 98 cases and a report of 8 new cases. Obstet Gynecol Surv (1973) 1.38
Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. J Histochem Cytochem (1993) 1.24
Carcinoma in situ of the vulva: a continuing challenge. Am J Obstet Gynecol (1980) 1.21
Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J (1996) 1.20
Use of patient's natural crown as the pontic in a composite resin-retained temporary bridge. Aust Dent J (1983) 1.12
Cystic mesothelioma of the peritoneum. Radiology (1989) 1.11
Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade. J Urol (1997) 1.11
Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. Mod Pathol (1993) 1.10
Duplicated inferior vena cava simulating retroperitoneal lymphadenopathy in a patient with embryonal cell carcinoma of the testicle. J Urol (1986) 1.06
Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. J Urol (1975) 1.03
Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction. Cancer (1998) 1.03
Videotaped vs traditional lectures for medical students. Med Educ (1980) 1.00
Laser treatment of cervical and vaginal neoplasia. Am J Obstet Gynecol (1977) 0.98
Two new, direct, and specific methods of acid phosphatase determination. National field trial. Urology (1979) 0.98
Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu (1982) 0.97
Chemotherapy of advanced, hormonally resistant prostatic carcinoma. Oncology (1980) 0.96
Paramagnetic changes in cancer: DMBA-induced tumours studied in non-lyophilized and lyophilized tissues. Br J Cancer (1979) 0.96
Microinvasive carcinoma of the vulva. Int J Gynecol Pathol (1982) 0.96
Simple cystectomy in patients requiring urinary diversion. J Urol (2000) 0.95
New nomenclature for vulvar disease: International Society for the Study of Vulvar Disease. Hum Pathol (1989) 0.95
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA (1987) 0.95
Letter: Benign transformation of testicular carcinoma by chemotherapy. Lancet (1975) 0.94
Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin. Cancer Chemother Rep (1975) 0.94
Intraoperative autotransfusion in urologic oncology. Arch Surg (1986) 0.94
The histopathology of vulvar vestibulitis syndrome. Int J Gynecol Pathol (1988) 0.93
Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation. Role of P-selectin. Arterioscler Thromb Vasc Biol (1995) 0.92
Clinical delineation of trisomy 9 syndrome. Obstet Gynecol (1980) 0.92
Pilot study of the tolerability and toxicity of intravesical valrubicin immediately after transurethral resection of superficial bladder cancer. Urology (2000) 0.92
Primary malignant melanoma of the male urethra. J Urol (1988) 0.92
Paradoxical increase of renal blood flow in anesthetized hypertensive dog treated with indomethacin. Urology (1979) 0.90
Vaginal columnar cell metaplasia. An acquired adenosis associated with topical 5-fluorouracil therapy. J Reprod Med (1995) 0.90
Intravesical bacillus Calmette-Guerin for patients with high-risk superficial bladder cancer. Urology (1991) 0.90
Transverse colon conduit: a method of urinary diversion after pelvic irradiation. J Urol (1982) 0.90
Correlation between cervical cytologic results and Gram stain as diagnostic tests for bacterial vaginosis. Am J Obstet Gynecol (1997) 0.90
Laparoscopic colorectal cancer surgery in obese patients. Colorectal Dis (2010) 0.90
Benign cellular changes in Pap smears. Causes and significance. Acta Cytol (2001) 0.89
Quality control considerations for Ki-67 detection and quantitation in paraffin-embedded tissue. J Cell Biochem Suppl (1994) 0.88
Flow cytometric analysis and cytopathology of body cavity fluids. Acta Cytol (1987) 0.88
Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin. J Urol (1976) 0.88
Association of Fanconi's anemia and squamous-cell carcinoma of the lower female genital tract with condyloma acuminatum. A report of two cases. J Reprod Med (1984) 0.88
Alpha-fetoprotein and endodermal sinus tumor of the ovary. Am J Obstet Gynecol (1973) 0.87
Current status of classification and staging of prostate cancer. Cancer (1980) 0.87
Fine-needle aspiration of metastatic lesions and regional lymph nodes in genitourinary cancer. Urology (1982) 0.87
Massive bleeding from ileal conduit peristomal varices: successful treatment with the transjugular intrahepatic portosystemic shunt. J Urol (1998) 0.87
Multimodal therapy for neoplasms arising from a vesical diverticulum. J Surg Oncol (1996) 0.87
Treatment of testicular tumors arising in patients with previous inguinal and/or scrotal surgery. J Urol (1982) 0.86
Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol (1984) 0.86
Therapeutic embolization of pelvic metastases of renal cell carcinoma. J Urol (1984) 0.86
Prognostic factors in localized prostatic carcinoma. J Urol (1985) 0.86
Measurements of prolactin and androgens in patients with prostatic diseases. Oncology (1980) 0.85
How complete is influenza immunization coverage? A study in 75 nursing and residential homes for elderly people. Br J Gen Pract (1995) 0.85
Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors. Gynecol Oncol (1989) 0.84
Hypothalamo-pituitary-adrenal axis in patients with prostatic carcinoma. Oncology (1980) 0.84
Mesenchymal hamartoma of the liver. DNA flow cytometric analysis of eight cases. Cancer (1994) 0.84
Current results from treatment of bladder tumors with total cystectomy at roswell park memorial institute. J Urol (1975) 0.84
DNA tetraploidy in Feulgen-stained bladder washings assessed by image cytometry. Anal Quant Cytol Histol (1995) 0.84
Carcinoembryonic antigen and L-fucose in malignant and benign mammary disease. Am J Clin Pathol (1980) 0.83
Keratoacanthoma: a deficient squamous cell carcinoma? Study of bcl-2 expression. J Cutan Pathol (1994) 0.83
Superior vena cava syndrome in a 56-year-old man. J Urol (1981) 0.83
Hemangiopericytoma of the Urinary Bladder: a case report and review of the literature. J Surg Oncol (1976) 0.83
Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc Res (1994) 0.83
Lymph node evaluation in prostatic cancer: is pelvic lymph node dissection necessary? Urology (1981) 0.83
Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up. Urology (1995) 0.83
Screening the newborn for Duchenne muscular dystrophy: parents' views. Br Med J (Clin Res Ed) (1983) 0.83
Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study. Mol Urol (2001) 0.83
The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Urology (1994) 0.82
Preoperative angioinfarction of localized renal cell carcinoma using absolute ethanol. J Urol (1985) 0.82
Pulmonary mucormycosis diagnosed by bronchoalveolar lavage: a case report and review of the literature. Pediatr Pulmonol (1997) 0.82
Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III). Cancer (1976) 0.82
Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. J Urol (1984) 0.82
Immediate postoperative feeding in urological surgery. J Urol (1984) 0.81
Turner's syndrome with endometrial adenocarcinoma and stilbestrol therapy. Obstet Gynecol (1973) 0.81
Recurrent squamous cell carcinoma of the cervix within pelvic-abdominal lymphocysts. Obstet Gynecol (1983) 0.81
Morphometric analysis of AgNORs in imprints and sections from non-Hodgkin's lymphomas. An approach to standardization. Anal Quant Cytol Histol (1993) 0.81
Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet (1989) 0.80
Do qualifiers of ASCUS distinguish between low- and high-risk patients? Acta Cytol (1999) 0.80
Pseudo-Paget's Disease of the Vulva: A Case Report. J Low Genit Tract Dis (1999) 0.80
Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology (1992) 0.80
Prognostic factors in carcinoma of the vulva: a clinicopathologic and DNA flow cytometric study. Int J Gynecol Pathol (1996) 0.80
Transitional cell carcinoma of ileal loop following cystectomy. Urology (1975) 0.79
Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients. J Urol (1980) 0.79
A multilabeling technique for simultaneous demonstration and quantitation of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue. J Histochem Cytochem (1994) 0.79
Androgen deprivation with salvage surgery for radiorecurrent prostate cancer: results at 5-year followup. J Urol (1998) 0.79
Changing concepts in the treatment of advanced seminomatous tumors. J Urol (1983) 0.78
Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. J Urol (1991) 0.78
Application of laser scanning cytometry for evaluation of DNA ploidy in routine cytologic specimens. Diagn Cytopathol (2001) 0.78
Aggressive uterine sarcoma with rhabdoid features: diagnosis by peritoneal fluid cytology and absence of INI1 gene mutation. Hum Pathol (2001) 0.78
Vulvar intraepithelial neoplasia and skin appendage involvement. Obstet Gynecol (1989) 0.78
Superficial invasive carcinoma of the vulva. Clin Obstet Gynecol (1985) 0.78